Modern approaches to rabies treatment: problems, research and new perspectives

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The article analyzes scientific research on the treatment and prevention of rabies. The role of modern approaches to rabies treatment, international experience and recommendations, and new experimental strategies, including immunotherapy using interferon inducers, is shown using the example of the domestic Amphievovir dietary supplement, positioned as a potential treatment for viral infections, including rabies. Amphievovir is intended for topical and sublingual use, which ensures the gradual entry of the inducer into the body and a predominantly local effect, which increases the safety and convenience of use for patients. Data from domestic studies demonstrate that Amphievovir has successfully passed preclinical safety tests and has pronounced antiviral activity of a wide range. It is important to continue multicenter research on rabies therapy, possibly combining the efforts of virologists, clinicians and pharmacologists from different countries.

全文:

受限制的访问

作者简介

T. Potupchik

Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Ministry of Health of Russia

编辑信件的主要联系方式.
Email: potupchik_tatyana@mail.ru
ORCID iD: 0000-0003-1133-4447
SPIN 代码: 8353-3513

Candidate of Medical Sciences

俄罗斯联邦, Krasnoyarsk

S. Generalov

Russian Anti-Plague Research Institute «Microbe» of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing

Email: potupchik_tatyana@mail.ru
ORCID iD: 0000-0003-1461-5383
SPIN 代码: 4130-2475

Candidate of Biological Sciences; Associate

俄罗斯联邦, Saratov

M. Khabibulina

Ural State Medical University, Ministry of Health of Russia

Email: potupchik_tatyana@mail.ru
ORCID iD: 0000-0002-3240-1357
SPIN 代码: 3456-9089

Associate Professor, Candidate of Medical Sciences

俄罗斯联邦, Yekaterinburg

A. Spitsyn

LLC «SPA Evolution of Nature»

Email: potupchik_tatyana@mail.ru
ORCID iD: 0009-0005-4900-826X
俄罗斯联邦, Novosibirsk

E. Shenderovich

N.F. Gamaleya Research Institute of Epidemiology and Microbiology, Ministry of Health of Russia

Email: potupchik_tatyana@mail.ru
ORCID iD: 0009-0003-3382-1411
俄罗斯联邦, Moscow

参考

  1. Zheng J., Sui B., Zhao L. Rabies lyssavirus. Veterinary Virology of Domestic and Pet Animals. Cham: Springer Nature Switzerland, 2025.
  2. Всемирная организация здравоохранения. Бешенство: основные факты, 2023 [World Health Organization. Rabies: Key facts, 2023 (in Russ.)]. URL: https://www.who.int/ru/news-room/fact-sheets/detail/rabies
  3. Об обстановке по бешенству животных, заболеваемости бешенством людей в России и на территории Костромской области, мерах профилактики бешенства среди людей и животных. Роспотребнадзор [On the situation of animal rabies, the incidence of human rabies in Russia and in the Kostroma region, and measures to prevent rabies among humans and animals. Rospotrebnadzor. (in Russ.)]. URL: https://44.rospotrebnadzor.ru/profilaktika_infekci/3166/#:~:text=В%20Российской%20Федерации%20с%202012,получении%20людьми%20у%D
  4. Gompf S.G. Rabies Treatment and Management. Updated: Mar 07, 2024. URL: emedicine.medscape.com/article/220967-treatment?form=fpf
  5. WHO Expert Consultation on Rabies, third report. Geneva: World Health Organization; 2018 (WHO Technical Report Series, No. 1012); 195
  6. Старков Ф.И., Шалин В.В., Миронов В.С. и др. Милуокский протокол – от идеи до реализации. Медицинский вестник Юга России. 2023; 14 (3): 59–65 [Starkov F.I., Shalin V.V., Mironov V.S. et al. The Milwaukee Protocol – from idea to implementation. Medical Bulletin of the South of Russia. 2023; 14 (3): 59–65 (in Russ.)]. doi: 10.21886/2219-8075-2023-14-3-59-65
  7. Jackson A. Demise of the Milwaukee Protocol for Rabies. Clin Infect Dis. 2025; ciaf157. doi: 10.1093/cid/ciaf157
  8. Lacy M., Phasuk N., Scholand S.J. Human Rabies Treatment – From Palliation to Promise. Viruses. 2024; 16 (1): 160. doi: 10.3390/v16010160
  9. Folkerth R. Neuropathology of First Human Rabies Virus Encephalitis Case Treated with Favipiravir and AAVRAB. Journal of Neuropathology and Experimental Neurology. 2023; 146 (6): 550–1.
  10. Yamada K., Noguchi K., Komeno T. et al. Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis. J Infect Dis. 2016; 213 (8): 1253–61. doi: 10.1093/infdis/jiv586
  11. Gribencha S.V., Nosik N.N., Ershov F.I. et al. Effectiveness of dsRNA as an interferon inducer in the intramuscular infection of mice with rabies street virus. Vopr Virusol. 1983; 2: 232–5.
  12. Scott T.P., Nel L.H. Rabies prophylactic and treatment options: an in vitro study of sirna- and aptamer-based therapeutics. Viruses. 2021; 13 (5): 881. doi: 10.3390/v13050881
  13. Brandão P.E., Castilho J.G., Fahl W. et al. Short-interfering RNAs as antivirals against rabies. Braz J Infec Dis. 2007; 11 (2): 224–5. doi: 10.1590/s1413-86702007000200011
  14. Ермолаев В.В., Шимина Г.Г., Аликин Ю.С. и др. Новые препараты иммуномодуляторов на основе РНК для лечения вирусных инфекций. Инновации и продовольственная безопасность. 2023; 4: 78–89 [Ermolaev V.V., Shimina G.G., Alikin Yu.S. et al. New RNA-based immunomodulator drugs for the treatment of viral infections. Innovation and food security. 2023; 4: 78–89 (in Russ.)]. doi: 10.31677/2311-0651-2023-42-4-78-89
  15. Даниленко Е.Д., Белкина А.О., Сысоева Г.М. Создание лекарственных препаратов на основе высокополимерных двуспиральных РНК для противовирусной и противоопухолевой терапии. Биомедицинская химия. 2019; 65 (4): 277–93 [Danilenko E.D., Belkina A.O., Sysoeva G.M. The creation of drugs based on high-polymer double-stranded RNAs for antiviral and antitumor therapy. Biomedical chemistry. 2019; 65 (4): 277–93 (in Russ.)]. doi: 10.18097/PBMC20196504277
  16. Амфиэвовир: Включите свой иммунитет. [Amphievovir: Turn on your immune system. (in Russ.)]. URL: https://leaderstoday.ru/archive/2023/7/amfievovir-vklyuchite-svoy-immunitet.html?ysclid=mdwhc8nalw628315080
  17. Амфиэвовир. Включи свой иммунитет. [Amphievovir. Turn on your immune system (in Russ.)]. URL: https://xn--80aeawcuqs4a5g.xn--p1ai/
  18. Генералов С.В., Перевозников Д.А., Абрамова Е.Г. и др. Противовирусная активность препарата на основе комплекса одноцепочечной высокополимерной РНК в отношении вируса бешенства in vitro. Вопросы биологической, медицинской и фармацевтической химии. 2025; 28 (8): 38–44 [Generalov S.V., Perevoznikov D.A., Abramova E.G. and others. Antiviral activity of the drug based on a complex of single-stranded high-polymer RNA against rabies virus in vitro. Problems of Biological, Medical and Pharmaceutical Chemistry. 2025; 28 (8): 38–44 (in Russ.)]. doi: 10.29296/25877313-2025-08-05
  19. Даниленко Е.Д., Гамалей С.Г., Батенева А.В и др. Исследование биологических свойств индуктора интерферона пролонгированного действия. Журнал микробиологии, эпидемиологии и иммунобиологии. 2011; 3: 57–61 [Danilenko E.D., Gamalei S.G., Bateneva A.V. et al. Biological properties of a prolonged action interferon inductor. Zh Mikrobiol Epidemiol Immunobiol. 2011; 3: 57–61 (in Russ.)].
  20. McMahon D., Winkelstein A., Huang X.L. et al. Acute reactions associated with the infusion of ampligen. AIDS. 1992; 6 (2): 235–6.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Russkiy Vrach Publishing House, 2025